Seaport Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	20.98	27.35
Research & Development	66.31	25.07
Total Operating Expenses	87.29	52.42
Operating Income	-87.29	-52.42
Interest Income	11.4	5.54
Other Non-Operating Income (Expense)	1.78	-
Total Non-Operating Income (Expense)	13.19	5.54
Pretax Income	-74.11	-46.88
Provision for Income Taxes	0.77	-
Net Income	-74.88	-46.88
Net Income to Common	-74.88	-46.88
Shares Outstanding (Basic)	2	1
Shares Outstanding (Diluted)	2	1
Shares Change (YoY)	151.76%	-
EPS (Basic)	-31.54	-49.72
EPS (Diluted)	-31.54	-49.72
Shares Outstanding	38.87	38.87
EBIT	-87.29	-52.42

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q